Evidence map›Paper›PMID 31623623›Full record

ArticleMalaria journal2019

Mosquitoes as a feasible sentinel group for anti-malarial resistance surveillance by Next Generation Sequencing of Plasmodium falciparum.

Rebecca Smith-Aguasca, Himanshu Gupta, Estefania Uberegui, Mara Maquina, Francisco Saute, Krijn P Paaijmans, Alfredo Mayor, Silvie Huijben

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Sampling for malaria molecular surveillance.Trends in parasitology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Rebecca Smith-AguascaISGlobal, Hospital Clínic - Universitat de Barcelona, 08036, Barcelona, Spain.
Himanshu GuptaISGlobal, Hospital Clínic - Universitat de Barcelona, 08036, Barcelona, Spain.
Estefania UbereguiISGlobal, Hospital Clínic - Universitat de Barcelona, 08036, Barcelona, Spain.
Mara MaquinaCentro de Investigação em Saúde da Manhiça (CISM), 1929, Manhiça, Mozambique.
Francisco SauteCentro de Investigação em Saúde da Manhiça (CISM), 1929, Manhiça, Mozambique.
Krijn P PaaijmansISGlobal, Hospital Clínic - Universitat de Barcelona, 08036, Barcelona, Spain.
Alfredo MayorISGlobal, Hospital Clínic - Universitat de Barcelona, 08036, Barcelona, Spain.
Silvie HuijbenISGlobal, Hospital Clínic - Universitat de Barcelona, 08036, Barcelona, Spain. silvie.huijben@asu.edu.ORCID http://orcid.org/0000-0002-3537-1915
Barcelona Institute for Global Health · ESManhiça Health Research Centre · MZ

Funding

Bill and Melinda Gates Foundation and Obra Social "la Caixa" Partnership for the Elimination of Malaria in Southern Mozambique OPP1115265Overseas Postdoctoral Fellowship program by the Science and Engineering Research Board, Department of Science & Technology, Government of India SB/OS/PDF-043/2015-16
6 · The paper itself

Abstract

backgroundPlasmodium falciparum drug resistance surveillance is key to successful disease control and eradication. Contemporary methods that only allow determination of prevalence of resistance are expensive, time consuming and require ethical considerations. A newer method involving Next Generation Sequencing (NGS) permits obtaining frequency of resistance while allowing to detect minority variants in mixed infections. Here, NGS was tested for P. falciparum resistance marker detection in mosquito samples as a feasible and suitable alternative for molecular resistance surveillance. Anopheles funestus were collected in southern Mozambique using CDC light traps and manual collections. DNA was extracted from either whole mosquito, head-thorax and abdomen separately or pools of five mosquitoes. These samples were screened for P. falciparum and if positive for k13, pfcrt, pfmdr1, pfdhps and pfdhfr mutations related to anti-malarial drug resistance with Sanger sequencing and NGS.

resultsAmong the 846 samples screened for P. falciparum, 122 were positive by 18S ssrDNA qPCR with an infection rate of 23.6%. No mutations were observed for k13 and pfcrt72-76 and almost zero for pfmdr86, but quintuple pfdhfr/pfdhps mutations were near fixation and about half of the isolates contained the pfmdr184F polymorphism. Similar allele frequencies of resistance markers were estimated with NGS in comparison with the prevalence of markers obtained with the gold standard Sanger sequencing.

conclusionsPooled deep sequencing of P. falciparum isolates extracted from mosquitoes is a promising, efficient and cost-effective method to quantify allele frequencies at population level which allows to detect known and unknown markers of resistance in single and mixed infections in a timelier manner. Using mosquitoes as sentinel group and focusing on allele frequency opposed to prevalence, permits active surveillance across a more homogeneous geographical range.

Indexed as

AnimalsAnophelesAntimalarialsDrug ResistanceFemaleHigh-Throughput Nucleotide SequencingMozambiquePlasmodium falciparumProtozoan ProteinsAntimalarialsProtozoan ProteinsAnopheles funestusDrug resistancek13MalariaMozambiquepfcrtpfdhfrpfdhpspfmdr1Sequencing

Identifiers

PMID31623623
PMCPMC6796398
OpenAlexW2980832852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.